Clinical Trials
31 trialsNeurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies
M.D. Anderson Cancer Center
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
Dana-Farber Cancer Institute
LTFS
Caribou Biosciences, Inc.
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
City of Hope Medical Center
Gene Therapy Follow-up Protocol for People Previously Enrolled in CAR-T Cell Studies
National Institutes of Health Clinical Center (CC)
Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study
City of Hope Medical Center
Cardio CAR-T
Assistance Publique - Hôpitaux de Paris
MMYLIFE
Azienda USL Reggio Emilia - IRCCS
Understanding the Risk of Blood Clots and Bleeding in Patients With Hematological Malignancies, HAT Study
Mayo Clinic
SANGUINE
JaxBio Ltd
Understanding What Matters Most to Patients: Establishing the Validity of a Best-Worst Scaling Survey
UNC Lineberger Comprehensive Cancer Center
HMvax-Regist
Wake Forest University Health Sciences
HemaTMA
Tampere University Hospital
ENROL
Hospital Universitari Vall d'Hebron Research Institute
COVID19-hematological Malignancies: the Italian Hematology Alliance
Ospedale di Circolo - Fondazione Macchi
AutoCOVID-19
Uppsala University
THERMAL
Malaghan Institute of Medical Research
HemoDiag
University Hospital, Montpellier
Rehabilitation Needs of the Malaysian Haematological Cancer Survivors
University of Malaya
Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplantation
Memorial Sloan Kettering Cancer Center
GAH
Celgene
N1
CureOne
PENELOPE Observational Study: Prophylaxis and Treatment of Arterial and Venous Thromboembolism
Gruppo Italiano Malattie EMatologiche dell'Adulto
Comprehensive Frailty Assessment
Ohio State University Comprehensive Cancer Center
A Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms
Celgene
Fungemia in Hematologic Malignancies
Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne
ADVANCE: An Observational Study To Determine Bortezomib Safety and Effectiveness at First Relapse After Participation In First Line HOVON-49/50 Clinical Studies.
Janssen-Cilag B.V.
VALEO: A Post Authorization Study, Designed to Learn More About the Safety and Effectiveness of the Use of Bortezomib in the Netherlands
Janssen-Cilag B.V.
Pilot Study of Reduced-Intensity Umbilical Cord Blood Transplantation in Adult Patients Wtih Advanced Hematopoietic Malignancies
University of California, San Francisco
Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia
University of California, San Francisco
Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients
Wyeth is now a wholly owned subsidiary of Pfizer